Abstract
Background/objectives
The definition of sarcopenia remains a matter of discussion and there is no globally accepted consensus for its diagnosis. The aim of this study was to assess the effect of sarcopenia diagnostic components on mortality, as well as to compare the associations between sarcopenia diagnosed via the 2010 and 2018 Consensuses of the European Working Group on Sarcopenia in Older People (EWGSOP) and mortality.
Methods
Prospective cohort study involving noninstitutionalized older adults aged ≥ 60 years. For the diagnosis of sarcopenia, the definitions proposed by the 2010 (EWGSOP) and 2018 (EWGSOP2) Consensuses were used. The diagnostic components corresponded to muscle mass, muscular strength, and physical performance. The associations of sarcopenia and its components with mortality were investigated using Cox proportional hazard regression models.
Results
The sample consisted of 1291 older adults. After an average of 2.6 years of follow-up, 88 (6.8%) participants had died. The diagnosis of severe sarcopenia by both Consensuses was associated with an increased risk of mortality. Severe sarcopenia was associated with an increased risk of death compared with that in people without sarcopenia when using EWGSOP (hazard ratio (HR) 3.15, 95% confidence interval (CI) 1.44–6.90) and EWGSOP2 (HR 4.11, 95% CI 1.88–9.00). Older adults with decreased gait speed had a 76% higher risk of dying (p = 0.033). There was no statistically significant association between the other sarcopenia components and mortality risk.
Conclusions
Older adults with severe sarcopenia and those with changes in physical performance had an increased risk of death in the short term.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MAF. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr. 2002;76:473–81.
Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127:994–7.
Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of Sarcopenia among the Elderly in New Mexico. Am J Epidemiol. 1998;147:755–63. https://doi.org/10.1093/oxfordjournals.aje.a009520.
Janssen I, Heymsfield SB, Ross R. Is associated with functional impairment and physical disability. J Am Geriatr. 2002;50:889–96.
Cawthon PM, Blackwell TL, Cauley J, Kado DM, Barrett-Connor E, Lee CG, et al. Evaluation of the usefulness of consensus definitions of sarcopenia in older men: results from the observational osteoporotic fractures in men cohort study. J Am Geriatr Soc. 2015;63:2247–59.
Woo J, Leung J, Morley JE. Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc. 2015;16:247–52. https://doi.org/10.1016/j.jamda.2014.11.013.
Kim H, Hirano H, Edahiro A, Ohara Y, Watanabe Y, Kojima N, et al. Sarcopenia: prevalence and associated factors based on different suggested definitions in community-dwelling older adults. Geriatr Gerontol Int. 2016;16:110–22. https://doi.org/10.1111/ggi.12723.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39:412–23.
Cruz-Jentoft, AJ, Bahat, G, Bauer, J, Boirie Y, Bruyère O, Cederholm T, et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48, 16–31.
Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc. 2011;12:249–56.
Barbosa-Silva TG, Bielemann RM, Gonzalez MC, Menezes AMB. Prevalence of sarcopenia among community-dwelling elderly of a medium-sized South American city: Results of the COMO VAI? study. J Cachexia Sarcopenia Muscle. 2016;7:136–43.
Barros AJD, Menezes AMB, Santos IS, Assunção MCF, Gigante D, Fassa AG, et al. O Mestrado do Programa de PósGraduação em epidemiologia da UFPel baseado em consórcio de pesquisa: Uma experiência inovadora. Rev Bras Epidemiol. 2008;11:133–44.
Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851–60. https://doi.org/10.1152/japplphysiol.00246.2003.
Bielemann RM, Gigante DP, Horta BL. Birth weight, intrauterine growth restriction and nutritional status in childhood in relation to grip strength in adults: from the 1982 Pelotas (Brazil) birth cohort. Nutrition. 2016;32:228–35. https://doi.org/10.1016/j.nut.2015.08.014.
Dodds RM, Syddall HE, Cooper R, Benzeval M, Deary IJ, Dennison EM, et al. Grip strength across the life course: normative data from twelve British studies. PLoS ONE. 2014;9:e113637.
Associação Brasileira de Empresas de Pesquisa (ABEP). Alterações na aplicação do Critério Brasil, válidas a partir de 2013. 2013. http://www.abep.org/novo/Content.aspx?ContentID=835.
Hellwig N, Munhoz TN, Tomasi E. Sintomas depressivos em idosos: estudo transversal de base populacional. Cien Saude Colet. 2016;21:3575–84. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232016001103575&lng=pt&tlng=pt.
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–95.
Buchner DM, Bishop J, Brown DR, Fulton JE, Galuska DA, Gilchrist J, et al. 2008 physical activity guidelines for Americans. 2008. www.health.gov/paguidelines. Accessed 2 Nov 2014.
Regina S, Pereira M. Independência em Atividades da Vida Diária (Escala de Katz). Cross-cultural adaptation of the Independence in Activities of Daily Living Index (Katz Index). Caderno de Saúde Pública 2008;24:103–12.
Beaudart C, Zaaria M, Pasleau F, Reginster J-Y, Bruyère O. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS ONE. 2017;12:e0169548. https://doi.org/10.1371/journal.pone.0169548.
Kelley GA, Kelley KS. Is sarcopenia associated with an increased risk of all-cause mortality and functional disability? Exp Gerontol. 2017;96:100–3. https://doi.org/10.1016/j.exger.2017.06.008.
Landi F, Calvani R, Tosato M, Martone AM, Bernabei R, Onder G, et al. Impact of physical function impairment and multimorbidity on mortality among community-living older persons with sarcopaenia: results from the ilSIRENTE prospective cohort study. BMJ Open. 2016;6:e008281. https://doi.org/10.1136/bmjopen-2015-008281.
Kim JH, Lim S, Choi SH, Kim KM, Yoon JW, Kim KW, et al. Sarcopenia: an independent predictor of mortality in community-dwelling older Korean men. J Gerontol A Biol Sci Med Sci. 2014;69:1244–52.
Bianchi L, Ferrucci L, Cherubini A, Maggio M, Bandinelli S, Savino E, et al. The predictive value of the EWGSOP definition of sarcopenia: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2016;71:259–64.
Cesari M, Pahor M, Lauretani F, Zamboni V, Bandinelli S, Bernabei R, et al. Skeletal muscle and mortality results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2009;64:377–84.
Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, et al. K V. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci. 2006;61:72–7.
Alexandre T, Duarte Y, Wong R, Lebrao M. Sarcopenia according to the European Working group on sarcopenia in older people versus Dynapenia as a risk factor for disability in elderly. J Nutr Health Aging. 2014;18:547–53.
Locquet M, Beaudart C, Hajaoui M, Petermans J, Reginster JY, Bruyère O. Three-year adverse health consequences of sarcopenia in community-dwelling older adults according to 5 diagnosis definitions. J Am Med Dir Assoc. 2019;20:43–46. https://doi.org/10.1016/j.jamda.2018.06.004.
Liu P, Hao Q, Hai S, Wang H, Cao L, Dong B. Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: a systematic review and meta-analysis. Maturitas. 2017;103:16–22.
Sim M, Prince RL, Scott D, Daly RM, Duque G, Inderjeeth CA, et al. Sarcopenia definitions and their associations with mortality in older Australian women. J Am Med Dir Assoc. 2019;20:76–82. https://doi.org/10.1016/j.jamda.2018.10.016.
Santos LP, Gonzalez MC, Orlandi SP, Bielemann RM, Barbosa-Silva TG, Heymsfield SB. New predictions equations to estimate appendicular skeletal muscle mass using calf-circumfernce: results from NHANES 1999–2006. JPEN J Parenter Enteral Nutr. 2019. https://doi.org/10.1002/jpen.1605.
Asai C, Akao K, Adachi T, Iwatsu K, Fukuyama A, Ikeda M, et al. Maximal calf circumference reflects calf muscle mass measured using magnetic resonance imaging. Arch Gerontol Geriatr 2019;83:175–8.
Acknowledgements
The authors thank the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and the the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for the financial support, and all the colleagues who collaborated on the COMO VAI? study.
Funding
First phase (2014) was funded by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) from Brazil and also by individual financial resources of the students. The second phase was partially funded by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Authors’ contributions
NPB and MCG planned the study. RMB and MCG performed the statistical analyses. NPB, RMB, AMBM, ET, TGBS and MCG wrote the paper. All authors approved the final version of the paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bachettini, N.P., Bielemann, R.M., Barbosa-Silva, T.G. et al. Sarcopenia as a mortality predictor in community-dwelling older adults: a comparison of the diagnostic criteria of the European Working Group on Sarcopenia in Older People. Eur J Clin Nutr 74, 573–580 (2020). https://doi.org/10.1038/s41430-019-0508-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-019-0508-8
This article is cited by
-
Impact of obesity on outcomes of patients with acute respiratory distress syndrome: a retrospective analysis of a large clinical database
Medizinische Klinik - Intensivmedizin und Notfallmedizin (2024)
-
Prevalence and determinants of sarcopenia in community-dwelling older adults in Ireland
Aging Clinical and Experimental Research (2023)
-
Relationship of body mass index with frailty and all-cause mortality among middle-aged and older adults
BMC Medicine (2022)
-
Cutoff Points for Grip Strength in Screening for Sarcopenia in Community-Dwelling Older-Adults: A Systematic Review
The Journal of nutrition, health and aging (2022)
-
Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review
Aging Clinical and Experimental Research (2022)